Life Science Research Services Market Revenue to Attain USD 96.26 Bn by 2035
Published: 17 Dec 2025
Author: Precedence Research
Life Science Research Services Market Revenue and Trends 2026 to 2035
The global life science research services market revenue was valued at USD 35.37 billion in 2025 and is expected to attain around USD 96.26 billion by 2035, growing at a CAGR of 10.53% during forecast period. This market is experiencing unprecedented growth, driven by the rising demand for personalized medicine and the increasing complexity of biologics.
What Are the Factors That Have a Significant Contribution to the Growth of the Life Science Research Services Market?
The rising burden of chronic diseases such as cancer, diabetes, and heart disease, and the surge in the geriatric population, are the major drivers, accelerating the growth of the life science research services market during the forecast period. The rapid adoption of advanced technology, such as AI/Machine Learning, CRISPR, Next Generation Sequencing (NGS), and other digital tools, is likely to accelerate the discovery and data analysis process. Additionally, significant investment in R&D activities and the expansion of biotech startups, particularly in developed and developing economies, are expected to fuel growth in the life science research services market.
Segment Insights
- By service type, the clinical research services segment held the largest market share in 2024. The segment’s growth is primarily driven by the increasing reliance on Contract Research Organizations (CROs) for outsourcing R&D activities and rising spending on clinical research services by pharmaceutical and biotechnology companies to discover new drugs and therapies.
- By therapeutic area, the oncology segment held the largest market share in 2024, owing to the increasing global prevalence of cancer, rising R&D investment, and rising demand for faster treatment. CROs are playing a crucial role in trials and drug development for advanced cancer therapies.
- By end user, the pharmaceutical companies segment held the largest market share in 2024. Pharmaceutical companies are increasingly investing in R&D to develop new drugs and innovative therapies to address unmet medical needs.
- By technology platform, the high-throughput screening segment held the largest share in the life science research services market during 2024. The segment’s growth is driven by rising demand for drug discovery for chronic diseases, the need for automation, and the integration of sophisticated technologies such as AI/ML into key applications in target identification and toxicology assessment.
Regional Insights
North America holds the dominant share in the global life science research services market. The region’s leadership is driven by the presence of well-established healthcare infrastructure, rapid growth in personalized medicine, the increasing geriatric population, the rise of specialized contract research models, the growing demand for faster data analysis, and the increasing burden of chronic diseases. Moreover, the rising demand for advanced therapies and the growing shift toward AI-driven research are expected to drive growth in the life science research services market during the forecast period.
On the other hand, the Asia Pacific region is anticipated to grow at the fastest rate in the market during the forecast period. The region's fastest growth is attributed to the developing healthcare sector, rising R&D spending, increasing demand for personalized medicine, the rising outsourcing trend, rapid technological progress, a supportive government framework, an aging population, and an increasing patient population with chronic diseases. In addition, the growing expansion of pharma, biotech, and CROs is likely to drive growth in the life science research services market in the coming years.
Life Science Research Services Market Coverage
| Report Attribute | Key Statistics |
| Market Revenue in 2025 | USD 35.37 Billion |
| Market Revenue by 2035 | USD 96.26 Billion |
| CAGR from 2026 to 2035 | 10.53% |
| Quantitative Units | Revenue in USD million/billion, Volume in units |
| Largest Market | North America |
| Base Year | 2025 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa |
Recent Developments
- In April 2024, Merck, a leading science and technology company, announced plans to invest more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the Life Science business sector will research solutions for manufacturing antibodies, mRNA applications, and additional products required for biotechnological production, among other things.(Source: https://www.merckgroup.com)
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7207
You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344